Reduces stroke by 44% and reduces kidney and eye disease for patients with Type 2 diabetes
Read More »Issue 109 Item 11 Cardiac Events Increased With High-Normal BP
Framingham study finding
Read More »Issue 110 Item 10 ADA: INTERNATIONAL RESEARCH LINKS INFLAMMATION AND TYPE 2 DIAB
So inflammation may be the common link for developing insulin resistance, diabetes, and heart disease. Insights Open New Pathways for Prevention and Treatment.
Read More »Issue 111 Item 14 ACC, AHA, NHLBI Clinical Advisory Confirms Safety, Effectivene
Joint Advisory Reassures Physicians, Patients About Drugs’ Importance in Lowering Cholesterol
Read More »Issue 107 Item 12 Recent-Onset Type 2 Diabetes Develop Albuminuria
Albuminuria can develop rapidly within the first few years after the onset of type 2 diabetes
Read More »Issue 108 Item 11 Simvastatin, Niacin Reduce Metabolic Syndrome Damage
Atherosclerotic progression was slowed; the rate of cardiac events dropped by 40%.
Read More »Issue 109 Item 10 Those with Normal Blood Pressure can Decrease Risk of Stroke a
ACE inhibitors cut the incidence of stroke, decrease stroke mortality, and reduce functional impairment following stroke in high-risk patients who have relatively normal blood pressure, reported Dr. Jackie Bosch and associates in the Heart Outcomes Prevention Evaluation (HOPE) study.
Read More »Issue 110 Item 9 ADA: The Effect of Orlistat on Glycemic Control Is Independent
Blood glucose improvements independent of weight loss.
Read More »Issue 111 Item 13 ADA: Artificial Pancreas Safe and Effective
An artificial pancreas without the need for injections found safe and effective.
Read More »Issue 107 Item 11 Advanced Glycation End Products (AGEs) Causes Endothelial Dysf
Study investigated whether changes in endothelium-dependent vasodilation, a marker of endothelial function, were related to serum AGEs concentrations in patients with type 2 diabetes.
Read More »